Inhibition of alkaline phosphatase by cysteine: Implications for calcium pyrophosphate dihydrate crystal deposition disease

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1313-1322

  So, Pauline P L ^a,b   Tsui, Florence W L ^c   Vieth, Reinhold ^a,b   Tupy, Jindra H ^a,b   Pritzker, Kenneth P H ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Alkaline phosphatase; Amino acids; Arthritis; Calcium pyrophosphate; Cartilage; Cysteine

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; CALCIUM ION; CALCIUM PYROPHOSPHATE; CYSTEINE; INORGANIC PYROPHOSPHATASE; MAGNESIUM ION;

ADULT; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; CALCIUM PYROPHOSPHATE; CHONDROCALCINOSIS; CRYSTALLIZATION; CYSTEINE; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; JOINTS; MALE;

EID: 34250175521     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Pritzker KPH. Pathology of osteoarthritis. In: Brandt KD, Lohmander S, Doherty M, editors. Osteoarthritis. Oxford: Oxford University Press; 1998:106-30.
2. Chateauvert JMD, Grynpas MD, Kessler MJ, Pritzker KPH. Spontaneous osteoarthritis in rhesus macaques. 11. Characterization of disease and inorphometric studies. J Rheumatol 1990;17:73-83.
3. Kandel RA, Renlund RC, Cheng PT, Rapley WA, Mehren KG, Pritzker KPH. Calcium pyrophosphate dihydrate crystal deposition disease with concurrent vertebral hyperostosis in a Barbary ape. Arthritis Rheum 1983;26:682-7.
4. McCarty DJ, Palmer DW, James C. Clearance of calcium pyrophosphate dihydrate crystals in vivo. Arthritis Rheum 1979;22:1122-31.
5. Markovic M, Fowler BO, Tung MS. Preparation and comprehensive characterization of a calcium hydroxyapatite reference material. J Res Natl Inst Stand Technol 2004;109:553-68.
6. Xu Y, Cruz TF, Pritzker KPH. Alkaline phosphatase dissolves calcium pyrophosphatase dihydrate crystals. J Rheumatol 1991;18:1606-10.
7. Xu Y, Pritzker KPH, Cruz TF. Characterization of chondrocyte alkaline phosphatase as a mediator in the dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1994;21:912-9.
8. Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001;281:C1-C11.
9. Cheng P-T, Pritzker KPH, Pyrophosphate, phosphate ion interaction: Effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions. J Rheumatol 1983;10:769-77.
10. Goding JW, Grobben B, Slegers H. Physiological and pathophysiological functions of the ectonucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 2003;1638:1-19.
11. Ryan LM, Rosenthal AK. Metabolism of extracellular pyrophosphate. Curr Opin Rheumatol 2003;15:311-4.
12. Graff RD, Picher M, Lee GM. Extracellular nucleotides, cartilage stress, and calcium crystal formation. Curr Opin Rheumatol 2003;15:315-20.
13. Picher M, Graff RD, Lee GM. Extracellular nucleotide metabolism and signaling in the pathophysiology of articular cartilage. Arthritis Rheum 2003;48:2722-36.
14. Tenenbaum J, Muniz O, Schumacher HR, Good AE, Howell DS. Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis. Arthritis Rheum 1981;24:492-500.
15. Anderson HC, Sipe JB, Hessle L, et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 2004;164:841-7.
16. Silcox DC, McCarty DJ. Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly and uremia. J Clin Invest 1973;53:1863-70.
17. Pritzker KPH. Calcium pyrophosphate crystal formation and dissolution. In: Amjad Z, editor. Calcium phosphates in biological and industrial systems. Boston: Kluwer Academic Publishers; 1998:277-301.
18. Ogata S, Hayashi Y, Takami N, Ikehara Y. Chemical characterization of the membrane-anchoring domain of human placental alkaline phosphatase. J Biol Chem 1988;263:10489-94.
19. Hamilton BA, McPhee JL, Hawrylak K, Stinson RA. Alkaline phosphatase releasing activity in human tissues. Clin Chim Acta 1989;186:249-54.
20. Pizauro JM, Ciancaglini P, Leone FA. Characterization of the phosphatidylinositol-specific phospholipase C-released form of rat osseous plate alkaline phosphatase and its possible significance on endochondral ossification. Mol Cell Biochem 1995;152:121-9.
21. Millan JL. Review. Alkaline phosphatases. Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signalling 2006;2:335-41.
22. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 2001;276:31171-8.
23. Hoylaerts MF, Manes T, Millan JL. Molecular mechanism of uncompetitive inhibition of human placental and germ-cell alkaline phosphatase. Biochem J 1992;286:23-30.
24. Kozlenkov A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, Millan JL. Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res 2004;19:1862-72.
25. Hoylaerts MF, Manes T, Millán JL. Mammalian alkaline phosphatases are allosteric enzymes. J Biol Chem 1997;272:22781-7.
26. Hui MZ, Tenenbaum HC, McCulloch CA. Collagen phagocytosis and apoptosis are induced by high level alkaline phosphatase expression in rat fibroblasts. J Cell Physiol 1997;172:323-33.
27. Mornet E. Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene. Hum Mutat 2000;15:309-15.
28. Bodansky O. Mechanism of inhibition of phosphatase activity by glycine. J Biol Chem 1946;165:605-13.
29. Bodansky O. The inhibitory effects of DL-alanine, L-glutamic acid, L-lysine, and L-histidine on the activity of intestinal, bone and kidney phosphatases. J Biol Chem 1948;174:465-76.
30. Fishman W, Sie HG. L-homoarginine; an inhibitor of serum "bone and liver" alkaline phosphatase. Clin Chim Acta 1970;29:339-41.
31. Lin CW, Fishman WH. L-Homoarginine. An organ-specific, uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem 1972;247:3082-7.
32. Fishman WH, Sie HG. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia 1971;41:141-67.
33. Fishman WH, Green S, Inglis NR. L-Phenylalanine: An organ-specific, stereo-specific inhibitor of human intestinal alkaline phosphatase. Nature 1963;465:685-6.
34. Lin CW, Fishman WH. L-tryptophan. A non-allosteric organ-specific uncompetitive inhibitor of human placental alkaline phosphatase. Biochem J 1981;124:509-16.
35. Pritzker KPH. Calcium pyrophosphate crystal arthropathy. A biomineralization disorder. Hum Pathol 1986;17:543-5.
36. Cox RP, Macleod CM, Repression of alkaline phosphatase in human cell cultures by cystine and cysteine. Proc Nat Acad Sci USA 1963;49:504-10.
37. Agus SG, Cox RP, Griffin MJ. Inhibition of alkaline phosphatase by cysteine and its analogues. Biochim Biophys Acta 1966;118:363-70.
38. Zhu CM, Chen QC, Lin HN, et al. Kinetics of inhibition of green crab (Scylla serrata) alkaline phosphatase by L-cysteine. J Protein Chem 1999;18:603-7.
39. Vovk AI, Muzychka OV, Kharchenko OV. Kinetics and mechanism of interaction of L-cysteine with calf intestine alkaline phosphatase [Russian]. Ukr Biokhim Zh 2003;75:35-9.
40. Cordoba F, Nimni ME. Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids. Osteoarthritis Cartilage 2003;11:228-30.
41. Giles NM, Watts AB, Giles GI, Fry FH, Littlechild JA, Jacob C. Metal and redox modulation of cysteine protein function. Chem Biol 2003;10:677-93.
42. Fukagawa NK, Galbraith RA. Advancing age and other factors influencing the balance between amino acid requirements and toxicity. J Nutr 2004;134:1569S-74S.
43. Jacobs DS, DeMott WR, Oxley DK. Laboratory test handbook. 5th ed. Hudson. OH: Lexi-Comp Inc.; 2001.
44. Cheng P-T, Pritzker KPH, Adams ME, Nyburg SC, Omar SA. Calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1980;7:609-16.
45. Hase M. KaleidaGraph 3.0.5. for Macintosh and Windows. Computer software reviews. J Am Chem Soc 1997;119:4323.
46. Kirsch PD, Ekerdt JG. KaleidaGraph: Graphing and data analysis. Version 3.5 for Windows. Computer software reviews. J Am Chem Soc 2000;122:11755.
47. Tommasini R, Endrenyi L, Taylor PA, Mahuran DJ, Lowden JA. A statistical comparison of parameter estimation for the Michaelis-Menten kinetics of human placental hexosaminidiase. Can J Biochem Cell Biol 1985;63:225-30.
48. m in enzyme reactions. Science 1952;116:329-31.
49. Cortes A, Cascante M, Cardenas ML, Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 2001;357:263-8.
50. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 1974;137:143-4.
51. Dixon M. The determination of enzyme inhibitor constants. Biochem J 1953;55:170-1.
52. Moss DW, Eaton RH, Smith JK, Whitby LG. Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem J 1967;102:53-7.
53. Cox RP, Gilbert P Jr, Griffin MJ. Alkaline inorganic pyrophosphatase activity of mammalian-cell alkaline phosphatase. Biochem J 1967;105:155-61.
54. Xu Y, Cruz TF, Cheng P-T, Pritzker KPH. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1991;18:66-71.
55. Shinozaki T, Xu Y, Cruz TF, Pritzker KPH. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals. J Rheumatol 1995;22:117-23.
56. Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 2000;86:69-74.
57. Giustarini D, Lorenzini S, Rossi R, Chindamo D, Di Simplicio P, Marcolongo R. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol 2005;23:205-12.
58. Kozlenkov A, Manes T, Hoylaerts MF, Millán JL. Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem 2002;277:22992-9.
59. Samiec PS, Drews-Botsch C, Flagg EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radical Biol Med 1998;24:699-704.
60. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol A: Biol Sci Med Sci 2006;61:1030-8.
61. Hunter GK, Grynpas MD, Cheng P-T, Pritzker KPH. Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels. Calcif Tissue Int 1987;41:164-70.
62. Bjelle AO. The glycosaminoglycans of articular cartilage in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (chondrocalcinosis articularis or pyrophosphate arthropathy). Calcif Tissue Int 1973;12:37-46.
63. Galperin MY, Bairoch A, Koonin EV. A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases. Protein Sci 1998;7:1829-35.
64. Gijsbers R, Ceulemans H, Stalmans W, Bollen M. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem 2001;276:1361-8.
65. O'Brien PJ, Herschlag D. Sulfatase activity of E. coli alkaline phosphatase demonstrates a functional link to arysulfatases, an evolutionarily related enzyme family. J Am Chem Soc 1998;120:12369-70.